In testing resistance to chemotherapy, our study showed that cisplatin treatment, with or without DPPIV knockdown, inhibited tumorigenesis, suggesting that DPPIV depletion could reduce tumor burden in EC. This evidence concerns the gene DPP4 and neoplasm.